Fibronectin type III domain-containing protein 4 is a protein that in humans is encoded by the FNDC4gene. This protein is cleaved into a smaller, secreted protein, soluble FNDC4 (sFNDC4) which activates the receptor ADGRF5 (previously called GPR116), triggering anti-inflammatory effects.
Function
The (long form) of the FNDC4 protein is a single-pass membrane protein, but it can also be cleaved into a secreted, soluble form: sFNDC4. FNDC4 is expressed most highly in the liver and brain, with the liver likely being the main source of sFNDC4 in the body. sFNDC4 signals to various cells and tissues. In the colon, it inhibits inflammatory macrophage activity. In bones, it appears to inhibit the differentiation of osteoclasts, which reduces the amount of bone that the body breaks down.
FNDC4 is also expressed by adipose tissue, functioning as an adipokine. In addition to local anti-inflammatory effects, sFNDC4 has been found to stimulate adipose tissue browning in human fat cells, This effect is mediated by its activation of the ADGRF5 receptor in white fat cells. Based on studies in mice, it is also predicted to increase the insulin sensitivity of fat cells.
Alternative names
FNDC4 has also been called Fibronectin type III repeat-containing protein 1 (FRCP1).